Why Orexigen Therapeutics, United Natural Foods, and United Continental Holdings Tumbled Today
Stocks tumbled today as fears of a global slowdown hit investor confidence. These three stocks also faced company-specific challenges.
Biotech Stock Roundup: Biogen Hemophilia Drug Approved, Ariad & Halozyme Clinical Hold Lifted - Anal
Biotech Stock Roundup: Biogen Hemophilia Drug Approved, Ariad & Halozyme Clinical Hold Lifted - Analyst Blog
Why Orexigen Therapeutics Inc. Shares Were Throttled
Orexigen shares get hammered after the FDA pushes back a key decision date. Find out what this means for shareholders.
Why Orexigen Therapeutics is Falling Today
Orexigen Therapeutics announced today that the regulatory decision for its obesity medication Contrave will be delayed by three months, causing shares to crater in early trading. Are investors overreacting?